AGP Executive Report
Last update: 10 hours agoBiotech & Health: AstraZeneca’s IMFINZI (durvalumab) won US FDA approval for BCG-naïve, high-risk non-muscle-invasive bladder cancer, marking a new immunotherapy combination option after decades with no major advances. Public Safety & Health Tech: Delaware advanced 911/988 coordination for behavioral health crises through new guidelines developed with DSAMH, HEALTHe Insights, and Mission Critical Partners. Food & Consumer Safety: Raaw Energy expanded a listeria-related pet food recall across multiple states including Delaware, with the FDA warning about ongoing exposure risks. Energy & Courts: Delaware’s Supreme Court upheld state law enabling an electrical substation tied to an offshore wind project, rejecting Fenwick Island and Sussex County’s challenge. Education & Local Infrastructure: Delaware transportation leaders rejected a nearly $900,000 grant for the ASPIRA Georgetown bilingual charter school, citing program rules that treat charter schools as public schools, not businesses. Logistics & Supply Chain Tech: PULPO WMS launched a 3PL client portal aimed at improving fulfillment visibility and collaboration for shippers. Agriculture & Competition: The US DOJ filed a statement in a Delaware seed-industry patent dispute, flagging market concentration concerns. Energy Prices: AAA reported Delaware gas prices averaging $4.22, down 12 cents week over week.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
